lambert-eaton-myasthenic-syndrome
1 cases — ← All topics
| Case | Title | Lower Court | Docketed | Status | Flags | Tags | Question Presented |
|---|---|---|---|---|---|---|---|
| 21-1342 | Jacobus Pharmaceutical Company, Inc. v. Catalyst Pharmaceuticals, Inc., et al. | Eleventh Circuit | 2022-04-11 | Dismissed | administrative-law circuit-split drug-exclusivity fda fda-regulation lambert-eaton-myasthenic-syndrome orphan-drug-act rare-disease statutory-interpretation | Does the Orphan Drug Act unambiguously foreclose FDA's interpretation that the scope of orphan-drug exclusivity is tied to a drug's approved use? |